Cadolac 30 mg Injection

Cadolac 30 mg Injection contains the active ingredient Ketorolac, which belongs to a class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). Ketorolac is a potent analgesic (pain reliever) and anti-inflammatory agent used for the short-term management of moderate to severe pain. Cadolac 30 mg Injection is administered via injection and provides rapid relief from pain associated with various conditions, including postoperative pain, musculoskeletal pain, and other acute pain conditions.

Key Ingredient:

Ketorolac: Ketorolac works by inhibiting the enzyme cyclooxygenase (COX), thereby reducing the production of prostaglandins, which are substances in the body that contribute to pain, inflammation, and fever. By blocking prostaglandin synthesis, Ketorolac helps alleviate pain and inflammation, providing symptomatic relief.

Uses:

Cadolac 30 mg Injection is indicated for the short-term management of moderate to severe pain in adults. It is commonly used for pain relief following surgical procedures, including dental surgery, orthopedic surgery, and minor surgical procedures. Cadolac Injection may also be used to manage acute musculoskeletal pain, such as back pain, joint pain, or traumatic injuries.

Dosage:

The dosage of Cadolac 30 mg Injection may vary depending on the severity of pain, individual patient factors, and the specific condition being treated. It is administered by healthcare professionals via intramuscular (IM) or intravenous (IV) injection. The recommended dosage for adults is typically 30 mg injected every 6 hours as needed for pain relief. The total duration of treatment with Cadolac Injection should not exceed 5 days due to the risk of adverse effects.

Precautions:

Before receiving Cadolac 30 mg Injection, inform your healthcare provider about any medical conditions you have, especially a history of gastrointestinal ulcers or bleeding, kidney impairment, asthma, or allergies to NSAIDs. Use caution when administering Cadolac Injection to elderly patients, as they may be more susceptible to adverse effects such as gastrointestinal bleeding and kidney damage. Avoid concomitant use of Cadolac Injection with other NSAIDs or medications that may increase the risk of bleeding.

Side Effects:

Common side effects of Cadolac 30 mg Injection may include:

• Nausea
• Vomiting
• Headache
• Dizziness
• Drowsiness
• Injection site reactions (pain, redness, swelling)
• Gastrointestinal upset (indigestion, abdominal pain)
• Increased risk of bleeding

These side effects are usually mild and transient. However, if you experience any severe or persistent side effects, contact your healthcare provider promptly for further evaluation and management.

FAQs:

1. How quickly does Cadolac 30 mg Injection provide pain relief? Cadolac Injection provides rapid pain relief, with onset of action occurring within 30 minutes of administration. The duration of pain relief typically lasts for 4 to 6 hours.
2. Can Cadolac 30 mg Injection be used for chronic pain management? Cadolac Injection is intended for short-term use only and is not recommended for chronic pain management. Prolonged use of NSAIDs may increase the risk of adverse effects, including gastrointestinal bleeding, kidney damage, and cardiovascular events.
3. Is Cadolac 30 mg Injection safe for use during pregnancy or breastfeeding? Cadolac Injection should be used with caution during pregnancy, especially during the third trimester, as it may cause adverse effects on the fetus. It is not recommended for use during breastfeeding due to the potential for excretion into breast milk and harm to the nursing infant.
4. What precautions should be taken when administering Cadolac 30 mg Injection? It is important to monitor renal function, blood pressure, and signs of gastrointestinal bleeding in patients receiving Cadolac Injection. Avoid concomitant use with other NSAIDs or anticoagulant medications unless directed by a healthcare provider.
5. Can Cadolac 30 mg Injection be used in children? Cadolac Injection is not recommended for use in children due to limited safety and efficacy data in pediatric populations. Consult a healthcare provider for alternative treatment options for pediatric patients requiring pain relief.